0       0

AST 2014 - Cutting Edge of Transplantation


FR02c - The Changing Face of Complement: Targeting in the Absence of Antibody


Feb 14, 2014 11:30am ‐ Feb 14, 2014 12:00pm

Description

Complement is well-known to be involved in antibody-mediated injury. New studies have implicated complement in the function of both regulatory and effector T cells. The underlying basis of this activity and possible therapeutic applications will be discussed.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content